The application of CAR-T cell therapy against solid tumors is often hindered by the dense and rigid tumor extracellular ...

Influencer Uorfi Javed shared her painful experience of lip filler dissolution. Experts weigh in on the procedure.

Huonslab Co., Ltd., a subsidiary of Huons Global (KOSDAQ:084110), announced that it has obtained a patent for the formulation without serum albumin of HYDIZYME™ (Recombinant Human Hyaluronidase PH20, ...

Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for ...

Uorfi Javed's recent selfies revealed dramatically swollen lips, sparking concerns about new fillers. However, she clarified ...

At both 4 weeks and 4 months, the 9-unit hyaluronidase injection sites were significantly less palpable than the 1.5-unit sites (mean difference, 0.5 and 0.47, respectively).

A new fight is brewing over the Medicare drug price negotiation program after the Trump administration proposed to consider ...

Hyaluronidase treatment for muscle spasticity is considered off-label. No pharmaceutical funding was received, and NYU Langone has filed a patent for hyaluronidase for muscle stiffness. RELATED TOPICS ...

Effect of hyaluronidase on rAAVCMVnlsLacZ transduction level. Muscles samples from animals receiving rAAVCMVnlsLacZ with or without hyaluronidase pretreatment, were processed as described in the ...

Patients received daratumumab and hyaluronidase-fihj administered subcutaneously with carfilzomib and dexamethasone. The primary endpoint was overall response rate. Results showed an overall ...

Since hyaluronidase’s role in aesthetics as an HA-filler reversal agent is not sanctioned by the FDA, this essential use is considered an off-label indication.

Huonslab Co., Ltd., a subsidiary of Huons Global (KOSDAQ:084110), announced that it has obtained a patent for the formulation without serum albumin of HYDIZYME™ (Recombinant Human Hyaluronidase ...